Our latest publication reports on the characterization of HOXA10-AS, a novel stem cell-specific lncRNA that is required for the maintenance of MLL-rearranged acute myeloid leukemias.

Our congratulations to Maurice, who won this year's Cord-Michael Becker Prize for his outstanding PhD work in the field of Molecular Medicine. This is a highly prestigious national award!

At this year's ISEH meeting in Brisbane, Australia, Dorit won both a travel award as well as a Young Investigator Prize for her short talk on EZH2 loss and co-operating mutations. We are so proud!

Our congratulations to Dirk Heckl, who has now officially joined the faculty of the Universitätsklinikum Halle as professor of Experimental Pediatrics, after more than a year apart.

Two of our papers went online this week! 1) Identification and validation of molecular events that drive progression from transient abnormal myelopoiesis to full-blown Down syndrome myeloid leukemia.

Two of our papers went online this week! 2) A review article on the regulatory roles of long noncoding RNAs in acute myeloid leukemia, including an updated catalog of functionally defined examples.

Another excellent PhD defense this year! Congratulations to Dr. rer. nat. Sofia Gialesaki, who graduated with a summa cum laude in June - among the first from the PhD program's entering class of 2015!

We are very proud of Sofia, who won a YoungEHA Best Abstract Award and presented the RUNX1 story to thousands during the EHA 2019 Presidential Symposium today. Yay Sofia!

Following an excellent thesis defense, Dr. rer. nat. Maurice Labuhn graduated with a summa cum laude from the HBRS Molecular Medicine PhD program. Many congratulations!

The TMD Prevention 2007 trial found that low-dose cytarabine treatment reduced mortality in TMD patients. However, this therapy did not prevent disease progression to ML-DS.